(Q27824867)

English

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

scientific article

Statements

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit